Published in N Engl J Med on June 02, 2016
CDX2 as a Prognostic Biomarker in Colon Cancer. N Engl J Med (2016) 0.75
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53